1.The detection of PCT,hs-CRP and WBC Applicated in Guangzhou area for children with bronchopneumonia
Liuqing CHEN ; Jufei LIAN ; Ziling LIU ; Kefeng LAI ; Wen ZENG
International Journal of Laboratory Medicine 2015;(14):2025-2026,2028
Objective Discussing the correlation between joint detection of procalcitonin(PCT) ,hypersensitive c‐reactive protein (hs‐CRP) ,WBC and bronchopneumonia in children .Methods Choosing 89 bacterial infection bronchopneumonia children ,92 virus infection bronchopneumonia children ,90 mycoplasma infection bronchopneumonia children and 100 normal children ,detecting their PCT ,hs‐CRP ,WBC and statistical analysis of the level of parallelism .Results There is a positive correlation between bacterial in‐fection group′s PCT and hs‐CRP ,WBC(r=0 .807 ,0 .764 ,P<0 .05) .The joint detection of PCT ,hs‐CRP ,WBC positive rate in bac‐terial infection group is significantly higher than the rest group(P<0 .05) .Conclusion PCT ,hs‐CRP and WBC is a sensitive indica‐tor of bacterial infection .There is important clinical reference value in joint detection to the diagnosis of bacterial infection broncho‐pneumonia in children ,in dynamic monitoring the disease progression ,and in prognosis judgement .
2.Research on the rule of ancient prescriptions of yin deficiency syndrome
Ziling ZENG ; Lin TONG ; Sihong LIU ; Fen JIANG ; Huamin ZHANG
International Journal of Traditional Chinese Medicine 2022;44(1):67-72
Objective:The data mining method was used to analyze the medication rules of the ancient prescriptions for yin deficiency syndrome, so as to provide reference for clinical treatment of yin deficiency syndrome.Methods:We searched the database of ancient prescriptions, selected the prescriptions for yin deficiency syndrome, used the Ancient and Modern Medical Case Cloud Platform V2.2.3 to count the frequency and attribute of drug use, and carried out hierarchical cluster analysis to find the core prescription. MATLAB was used to analyze the association rules, and the law of drug compatibility was found. The Pajek64 5.13 was used for complex network analysis to find out the core traditional Chinese medicine.Results:There were 467 prescriptions that meet the requirements, 302 kinds of drugs were used in total. The four properties of the drugs were mainly cold, the five flavors mainly sweet, the meridian of the drugs mainly kidney meridian. The core drugs were Rehmanniae Radix Praeparata, Ophiopogonis Radix, Rehmanniae Radix, and Poria. The most commonly used drug pair was Dioscoreae Rhizoma- Rehmanniae Radix Praeparata, the second was Corni Fructus- Rehmanniae Radix Praeparata, Poria-Rehmanniae Radix Praeparata. The commonly used drugs can be clustered into two categories. Conclusion:We can preliminarily reveal that the ancient medication law of yin deficiency syndrome is mainly nourishing Yin liquid and reducing fire, paying attention to nourishing kidney yin, using Yin nourishing medicine often combined with medicine of tonifying lung, liver, spleen yin and diverging to reduce fever. It can provide certain reference for clinical treatment of yin deficiency syndrome.
3.Clinical Application Analysis of Da Qinjiaotang Based on Ancient and Modern Literature
Hui ZHAO ; Lin TONG ; Lei ZHANG ; Sihong LIU ; Ziling ZENG ; Bin LI ; Huamin ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(9):1-7
Da Qinjiaotang is a common classical prescription for the treatment of stroke. It originates from Collection of Writings on the Mechanism of Disease, Suitability of Qi, and the Safeguarding of Life as Discussed in the Basic Questions (《素问病机气宜保命集》) by physician LIU Wansu, and is composed of Gentianae Macrophyllae Radix, Glycyrrhizae Radix et Rhizoma, Chuanxiong Rhizoma, Angelicae Sinensis Radix, Paeoniae Radix Alba, Asari Radix et Rhizoma, Notopterygii Rhizoma et Radix, Saposhnikoviae Radix, Scutellariae Radix, Gypsum Fibrosum, Angelicae Dahuricae Radix, Atractylodis Macrocephalae Rhizoma, Rehmanniae Radix, Rehmanniae Radix Praeparata, Poria, and Angelicae Pubescentis Radix. Doctors of all dynasties have disputed the composition principle of the prescription and argued whether its treatment of stroke belongs to the theory of "internal wind" or "external wind". Through collating and analyzing ancient and modern literature related to the indications of Da Qinjiaotang, this paper was dedicated to the origin of syndrome differentiation and treatment of Da Qinjiaotang. According to LIU Wansu's original works, Da Qinjiaotang is a prescription for the treatment of "internal wind", and in the prescription, wind medicinal herbs such as Gentianae Macrophyllae Radix, Notopterygii Rhizoma et Radix and Angelicae Pubescentis Radix removes stagnation, clears sweat pore, and makes qi and blood channels flow smoothly. However, later generations, affected by the idea of "external wind", believe that this prescription is used for the treatment of "external wind". Ancient physicians gradually supplemented the symptoms of stroke, such as wry eye and mouth, hemibody pain and limb numbness, which were treated by Da Qinjiaotang, and Da Qinjiaotang was also applied to the treatment of other diseases, such as tendon dryness, convulsion and arthralgia. Modern doctors still explain the disease pathogenesis from the theory of "external wind" as deficiency in channels and collaterals and the entry of pathogenic wind, and the prescription has the effect of dispersing wind, clearing heat and nourishing and activating blood. In clinical practice, Da Qinjiaotang is mainly used to treat cerebrovascular diseases and peripheral facial paralysis in nervous system diseases, gouty arthritis and rheumatic arthritis in the rheumatic immune system and skin diseases. The above findings facilitate the research and development of Da Qinjiaotang.
4.Study on the Mechanism of Prunus persica -Carthamus tinctorius Couplet Medicine in the Treatment of Osteonecrosis of the Femeral Head Based on Network Pharmacology
Hang DONG ; Yizi XIE ; Jiahua HUANG ; Shuliang JI ; Weipeng SUN ; Zhizhong SUN ; Xiashi ZENG ; Danting SHEN ; Ziling LIN
China Pharmacy 2019;30(7):917-922
OBJECTIVE: To study the mechanism of Prunus persica-Carthamus tinctorius couplet medicine in the treatment of osteonecrosis of the femoral head (ONFH). METHODS: The network pharmacology was adopted. The active components of P. persica -C. tinctorius couplet medicine and ONFH target were screened through TCM systematic pharmacological analysis platform target (TCMSP), DRAR-CPI, hnuman gene database (GeneCards) and online medelian inheritance in man (OMIM) using oral availability of compounds (OB)>30% and drug like (DL)>0.18 as standard. Network topology attribute analysis software Cytoscape 3.6.0 was utilized to construct the active components-ONFH targets network. Target protein interaction network was established on the basis of STRING database, and top 5 target proteins in the list of connectivity were screened, and molecular docking server was used to predict the combination activity of active components from P. persica -C. tinctorius couplet medicine. The biological processes of target gene ontology (GO) and metabolic pathways in Kyoto encyclopedia of genes and genomes (KEGG) were enriched and analyzed by DAVID. RESULTS: A total of 44 active components were screened from P. persica -C. tinctorius couplet medicine, including baicalin, quercetin, etc., and 78 targets related to ONFH including VEGF, VEGI, CRP, etc. Through analysis of molecular docking server, binding activity of active components of P. persica -C. tinctorius couplet medicine to target protein was strong. GO and KEGG pathway enrichment analysis showed that biological process of P. persica -C. tinctorius couplet medicine for ONFH was related with negative regulation of apoptosis process and positive regulation of nuclear factor-κB transcription factor, mainly through regulating secretory glycoprotein signaling pathway, melanogenesis signaling pathway, VEGF signaling pathway, signaling pathway of basal cell carcinoma, adenosine-activated protein kinase signaling pathway. CONCLUSIONS: This study preliminarily validates the major targets and pathways of P. persica -C. tinctorius couplet medicine for ONFH, which lay a foundation for further study on their pharmacological action.
5.Preliminary Discussion on Post-marketing Comprehensive Evaluation Indicator System of Ancient Famous Classical Formula Preparations
Danping ZHENG ; Lin TONG ; Lei ZHANG ; Ziling ZENG ; Bing LI ; Huamin ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(18):175-182
The construction of the comprehensive evaluation index system of the famous classical formula preparations after the marketing has both theoretical and practical significance. In this study, literature related to the post-marketing comprehensive evaluation of traditional Chinese medicine(TCM) compound preparations was retrieved from China National Knowledge Infrastructure(CNKI), China Science and Technology Journal Database(VIP), Wanfang Data Knowledge Service Platform(WanFang) and SinoMed from January 1, 2000 to April 30, 2022. CiteSpace 6.1.R2, a scientometrics software, was used to visualize the keywords involved, and to analyze the dynamic evolution trend and research hotspots in this field. Then, the existing comprehensive post-marketing evaluation index system of TCM compound preparations was screened and extracted, and the research status was systematically analyzed by mathematical statistics. It was found that there were problems such as the generalized boundaries between assessment dimensions and assessment elements, the lack of data sources for individual evaluation indexes, unset weight of some index system and insufficient application degree. In addition, according to the characteristics of famous classical formulas, the authors discuss the importance of evidence evaluation based on combination of disease and syndrome, pharmacovigilance of famous classical formulas preparations, and whole-process quality control of famous classical formulas, and put forward the construction strategy of comprehensive post-marketing evaluation of the famous classical formula preparations, which is oriented by clinical value, centered on evidence evaluation, and guaranteed by the whole-process quality control.